{"title":"Validation of the Kazakh-language version of the 8-item Morisky Medication Adherence Scale in patients with arterial hypertension.","authors":"Gulnaz Nuskabayeva, Kanatzhan Kemelbekov, Dilbar Aidarbekova, Yerbolat Saruarov, Nursultan Nurdinov, Kumissay Babayeva, Ugilzhan Tatykayeva, Elmira Iskandirova, Dinara Nemetova, Philip Morisky, Ainash Oshibayeva, Karlygash Sadykova","doi":"10.1080/20565623.2025.2569291","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The effectiveness of pharmacological therapies relies not only on the intrinsic efficacy of medicines, but also medication adherence, the extent to which patients follow their prescribed regimens. Patients with chronic conditions, such as hypertension, are at an increased risk of exhibiting poor medication adherence. Therefore, identifying patients with poor medication adherence is an important aspect of treatment success.</p><p><strong>Research design and methods: </strong>The present study aims to translate and adapt the Morisky Medication Adherence Scale (MMAS-8), a self-reporting questionnaire to assess patients' adherence to prescribed therapy.</p><p><strong>Results: </strong>The study validated the translated questionnaire and assessed its psychometric properties among a cohort of 400 patients with arterial hypertension in Turkistan region in southern Kazakhstan. The findings of the present study show that the Kazakh version of the MMAS-8 possesses high validity, reliability, and internal consistency, thereby confirming its appropriateness as a reliable tool for assessing medication adherence among patients with arterial hypertension in Kazakhstan.</p><p><strong>Conclusion: </strong>The psychometric properties of the Kazakh adaptation were comparable to those of the original English version and other validated non- English versions of the MMAS-8.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2569291"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2025.2569291","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The effectiveness of pharmacological therapies relies not only on the intrinsic efficacy of medicines, but also medication adherence, the extent to which patients follow their prescribed regimens. Patients with chronic conditions, such as hypertension, are at an increased risk of exhibiting poor medication adherence. Therefore, identifying patients with poor medication adherence is an important aspect of treatment success.
Research design and methods: The present study aims to translate and adapt the Morisky Medication Adherence Scale (MMAS-8), a self-reporting questionnaire to assess patients' adherence to prescribed therapy.
Results: The study validated the translated questionnaire and assessed its psychometric properties among a cohort of 400 patients with arterial hypertension in Turkistan region in southern Kazakhstan. The findings of the present study show that the Kazakh version of the MMAS-8 possesses high validity, reliability, and internal consistency, thereby confirming its appropriateness as a reliable tool for assessing medication adherence among patients with arterial hypertension in Kazakhstan.
Conclusion: The psychometric properties of the Kazakh adaptation were comparable to those of the original English version and other validated non- English versions of the MMAS-8.
期刊介绍：
Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
